1162P Clinical research platform into molecular testing, treatment and outcome of non-small cell lung carcinoma patients (CRISP): First real-world evidence of NSCLC stage II and III in Germany - AIO-TRK-0315

Autor: Gröschel, A., Passlick, B., Stuschke, M., Christopoulos, P., Reck, M., Grah, C., Groth, A., Hipper, A., Chiabudini, M., Fleitz, A., Jänicke, M., Spring, L., Christoph, D.C., Bernhardt, C., Reiser, M., Zahn, M-O., Sebastian, M., Griesinger, F., Thomas, M., Eberhardt, W.E.E.
Zdroj: In Annals of Oncology September 2021 32 Supplement 5:S935-S936
Databáze: ScienceDirect